AlphaStocks
6.3
Consider Buy

Elevance Health, Inc. (ELV)

As of Sep 20, 2026, Elevance Health, Inc. (ELV) scores 6.3/10 on AlphaStocks' five-model composite, #34 of 168 Health Care stocks. At $411, ELV trades 30% below its model fair value of $588.

Health Care / Managed Health Care

S&P 500

$410.92

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 5 of 5 models — high confidence

Data as of Sep 20, 2026

#34out of 168 in Health Care

Is Elevance Health, Inc. a Good Investment in 2026?

Elevance Health, Inc. (ELV) scores 6.3 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates Elevance Health, Inc. as Attractive (6/9). However, the Graham model rates it Caution — 25% above fair value. Elevance Health, Inc. currently trades 30% below its estimated fair value of $588. Elevance Health, Inc. ranks #34 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E16.3ROE12.9Market Cap91BDiv Yield1.7

Estimated Fair Value

$587.5130% below

Trading below estimated fair value. P/E of 16x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Neutral

Business quality & competitive moat

Graham

Caution

25% above fair value

Lynch

Neutral

PEG 1.5 · Stalwart

Greenblatt

Attractive

Earnings yield 6.2% · ROC 27%

Frequently Asked Questions

Is Elevance Health, Inc. (ELV) a good investment?
As of Sep 20, 2026, Elevance Health, Inc. (ELV) scores 6.3/10 on AlphaStocks' five-model composite, #34 of 168 Health Care stocks. At $411, ELV trades 30% below its model fair value of $588. That is a middle-of-the-pack score with no strong signal either way.
What is Elevance Health, Inc.'s Piotroski F-Score?
Elevance Health, Inc.'s Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is ELV overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $588, ELV appears undervalued. The stock currently trades 30% below its estimated fair value. Trading below estimated fair value. P/E of 16x is moderate for this quality level.
How does ELV compare to other Health Care stocks?
Elevance Health, Inc. ranks #34 out of 168 stocks in the Health Care sector, placing it in the top 20% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about ELV?
AlphaStocks evaluates ELV using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Caution; Lynch: Neutral; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 6.3/10.

Similar Stocks

MOHHQYUNH

Compare ELV with

ELV vs MOHELV vs HQYELV vs UNHELV vs VALELV vs PARRELV vs FTI

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer